Senator Bernie Sanders is taking aim at the exorbitant prices of weight-loss drugs Ozempic and Wegovy, manufactured by a Danish pharmaceutical company. These drugs, which have become incredibly popular in the United States, are priced at a rate that is ten times higher than in other countries. Wegovy and Ozempic have become household names in America, often associated with celebrities like Oprah Winfrey and touted as life-changing by medical professionals. However, the high demand for these drugs, which are used not only by individuals with diabetes but also by those struggling with obesity, has highlighted a major issue in the American healthcare system - the cost of medication. Senator Sanders plans to question the CEO of the pharmaceutical company responsible for these drugs about the pricing disparity between the US and other countries. The inflated prices of Wegovy and Ozempic are seen as unacceptable, especially considering the significant impact they can have on individuals' health and well-being. The debate over the cost of these weight-loss drugs reflects a larger issue within the healthcare industry in the US, where medication prices often put a strain on individuals and families. Sanders' efforts to address this issue are part of a broader push for more affordable and accessible healthcare for all Americans.

Another Canadian scientist has come forward to allege that the government halted an investigation into a mysterious brain illness in New Brunswick. Professor Samuel Weiss, in a leaked email, stated that efforts to tackle the illness were stopped by the government. He believes that the illness may have affected around 350 people, a higher number than what the government has acknowledged. This is the second federal scientist to accuse the government of deliberately shutting down the investigation into the brain illness.

A criminal group has reportedly published online data from the NHS cyber attack that resulted in the cancellation of operations. The attack is believed to have been orchestrated by the Russian group Qilin.

Jasmine, a patient suffering from endometriosis, is just one of the many individuals waiting for treatment within the NHS. The number of people seeking care for this condition has significantly increased, leaving many in a state of distress. Jasmine's pain is so severe that it has become a challenge for her to even get out of bed. This highlights the urgent need for improved access to healthcare services for those battling endometriosis.

During a recent debate, several key claims were made regarding taxes, the economy, NHS waiting lists, and small boats. BBC Verify examined these claims to determine their accuracy. One claim that was discussed was related to taxes. It is important to verify the accuracy of statements made about tax policies and their impact on the economy. Another claim focused on NHS waiting lists, which are a crucial issue affecting the healthcare system. It is essential to fact-check information regarding waiting times and access to healthcare services. Additionally, the debate touched on the topic of small boats. Claims were made about the significance of small boats in various contexts, such as trade or immigration. It is important to verify the accuracy of statements made about the role of small boats in different industries and sectors. Overall, BBC Verify conducted tests to verify the key claims made during the debate, shedding light on the accuracy of information presented to the public.